Dr. med. Peter Tinnemann is physician and health researcher at the Charité Universitätsmedizin Berlin with particular interest in social medicine, access to health care and health in a globalizing world. He holds a Master degree in Public Health from Cambridge University and has more than 10 years work experience with various international humanitarian aid organisations, e.g. Doctors without Boarders (MSF). In 2012 he found the association "Certified Medical Independence" training doctors in rational drug therapy. 

Dr Tim Reedhas more than 30 years of experience in NGO management and medicines policy research. After directing a national UK-based charity for a decade, in 1997 Tim was awarded a BA Hons (first class) in Sociology with Development Studies from the University of Sussex in the UK and specialised in the Sociology of Health and Development and the Politics of Pharmaceutical policy. In 2003, he obtained his doctorate from Sussex for his thesis “The regulation of medicines in Central and Eastern Europe”. He is one of the few holders of a PhD specifically in the politics of medicines regulation, and it led him to became a lecturer in health policy, medicines and development from 2003 to 2006. His work on related issues has been published in a number of books and peer-reviewed journals including Science, Technology, Society; the British Medical Journal; Health Risk & Society; Social Studies of Science and Social Science and Medicine. He also presented his work on medicines issues at numerous international conferences. Tim’s commitment to social equality in health led him to Health Action International’s European office in Amsterdam in 2005, where he became coordinator. First re-structuring the organization’s governance and accountability, and then re-building a vibrant global network, in 2007, he was appointed as the organization’s Global Director to manage global projects such as those conducted in partnership with WHO and the DFID sponsored Medicines Transparency Alliance (MeTA) international secretariat. 

Barbara Mintzes is an Assistant Professor with the School of Population and Public Health at the University of British Columbia and a member of the Therapeutics Initiative’s Drug Assessment Working Group, which carries out evaluations of the effectiveness and safety of new drugs. These reports are used as background information for provincial drug reimbursement decisions. The main focus of Dr Mintzes’ research is pharmaceutical policy, including the effects of direct-to-consumer advertising of prescription drugs on prescribing and medicine use. She is currently the principle investigator on an international comparative project examining the effects of different approaches to regulation on the safety-related information that pharmaceutical sales representatives provide to primary care physicians. Dr Mintzes was also a member of a Health Action International (HAI)/World Health Organization (WHO) project team that developed model curriculum for pharmacy and medical students on drug promotion and interactions with the pharmaceutical industry. She has worked for many years with women’s health and consumer groups, and is a member of the Steering Group of Women and Health Protection, La Revue Prescrire’s advisory committee, and HAI-Europe’s Board of Directors. Barbara Mintzes holds a PhD in health care and epidemiology from the University of British Columbia and is a Michael Smith Foundation for Health Research Scholar.

Dr. med. Nicola Kaatsch is a specialist physician for Children- and Adolescencemedicine. She works in the department of child and adolescent psychiatric service at the hopstial Diakoniekrankenhaus in Rotenburg/Wümme. Dr. Kaatsch wrote her thesis at the University of Hamburg about "The Psychosocial Impact of War and Violence on Health of Somali Children". Dr. Kaatsch was a co-worker of the research project at the McMaster University, Canada, at the center for International Health / Center for Peace Studies. She helped to develop fundamentals for an academic discipline called "Peace through Health". Dr. Kaatsch had been an IPPNW board member both local and international and had as well been board member of Doctors without Boarders (MSF). She was involved in projects of MSF in Kenya, Somalia, Sudan, Libanon and states of the former Sowjet Union.

Dr. med. Eva-Maria Schwienhorst is a medical doctor, has worked in paediatrics and now works in clinical tropical medicine. She holds a "Diploma of Tropical Medicine and Public Health" from Charité Berlin and is a candidate for a Master in International Health.  She is co-founder of Medinetz Mainz e.V. - a clearing house for refugees, migrants and people without personal documents.  In 2005, Eva-Maria Schwienhorst interned at the Centre of Peace Studies at McMaster University in Canada, where "Peace through Health" had been developed. Since 2006, she is the Deputy International Councillor of the German affiliate of IPPNW. Some of her main areas of interest are Global Health education, Medical Peace Work and migrant medicine.

Trevor Evans has an PhD in economics from the University of London. For many years he worked at the Regional Center for Economic and Social Research (CRIES) in Managua, Nicaragua, and has been a professor for economics at Berlin School of Economics since 2006. He is a member of coordinating committee of the European Economists for Alternative Economic Policy in Europe. 

Anna Zorzet graduated from the Master’s program of Molecular Biotechnology at Uppsala University in 2002. After working abroad in Australia with cancer research, she pursued a doctorate degree in medical microbiology. Her thesis work at the lab of professor Dan Andersson was in medical microbiology, with a focus on antibiotic resistance.  After working with bacterial resistance hands-on in the lab, she shifted gears to concentrate on policy action on antibiotic resistance, when she joined the international network ReAct (Action on Antibiotic Resistance) in Jan 2011.  At ReAct, she started working with the nodes of the ReAct Network as well as reviewing the scientific literature on antibiotic resistance. In 2012 she accepted the position of Assistant Executive Director at ReAct, working also with translating scientific evidence into policy action on national, regional and global levels. She is working with many of the regional and international networks on ABR, WHO and is on the Stakeholder Advisory Board for the major EU Joint Programming Initiative on AMR.

Dr. Christian Wagner-Ahlfs is a chemist and senior editor of the German health journal "Gute Pillen –Schlechte Pillen", informing about the use and risks of medicines. Since 2001 he works for the non-governmental organization BUKO Pharma-Kampagne, where he is engaged health and research politics. From 2005-2011 he was chairing the Association board of Health Action International (HAI) Europe and since 2011 he is part of the HAI Foundation board.

Clara Matthiessen is a 5th year medical student at the University of Copenhagen, Denmark. Clara has been involved in various global health activities since she started her medical studies, among others she has worked on access to the health care system for undocumented migrants. More than two years ago she joined the student organization Universities Allied for Essential Medicine (UAEM) in order to get more involved in access to medicine and pharma awareness. She has been member of UAEMs European Board since April 2012 and is currently the Chair of the Board.

Jörg Schaaber is a sociologist and Master of Public Health. He works for the German development NGO BUKO Pharma-Kampagne since 1981. He is the editor of Pharma-Brief, the newsletter of the organisation and executive officer of Gute Pillen – Schlechte Pillen, a lay drug bulletin which is a joint project of four German drug bulletins. Jörg Schaaber is a co-founder of Health Action International (HAI) and has been a member of the executive board of HAI-Europe from 1988-2001. He is a patient representative in the drug committee of the German public health insurance (G-BA). Since 2008 he is President of the International Society of Drug Bulletins (ISDB).

Tessel Mellema is a specialist in intellectual property (IP) law with specific expertise on the interplay of IP and EU policies that may have an impact on access to medicines within the EU and abroad. At Health Action International (HAI) Europe she is responsible for the EU Trade & Access, and Essential Innovation & Access campaigns. Areas of work include advocating for EU trade policies that are coherent with the EU’s commitments on health and development, campaigning for changes to the EU’s internal market laws that hamper access to medicines in Europe and advancing EU actions on the exploration of new models of biomedical innovation that promote needs-driven innovation and affordable access to resulting medical products. Prior to joining HAI, Tessel worked as an attorney-at-law for a large Dutch law firm, specialising in intellectual property law, with specific experience in the field of (bio)technology and life sciences. She has combined this legal experience with a Master’s degree in International Relations and a postgraduate course from the international think-tank Clingendael.

Sophie Bloemen is a Dutch national working as an independent advisor to civil society organisations in the field of intellectual property and access to medicines & knowledge. She is currently strategic advisor to Health Action International (HAI) Europe on their Access to Medicines, Trade and Essential Innovations projects. In her work she has focused on the EU Trade and innovation Agenda and global developments at the WHO on Public Health and Innovation. Sophie is a member of the Executive Committee of the Latin American & Caribbean-Global Alliance for Access to Medicines (Alianza LAC-Global), a network of South American and international health NGOs. She has travelled extensively to Latin America working in a coalition of civil society to monitor and advocate around trade negotiations and other access to medicines strategies in the region. Previously she worked as a project officer for Health Action International (HAI) Europe in the Netherlands and as trainee for the European Commission. Sophie obtained an MA in Philosophy and an MSc in International Relations from the University of Amsterdam and an MSc in European Political Economy from the London School of Economics. She has written several papers and articles on access to medicines, intellectual property and innovation.